Laurent Pascal

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM

Christian Rosé, Sabine Bréchignac, D. Vassilief et al. · Leukemia Research · 2010 · 195 citations

Medicine, Hematology, Pharmacotherapy +11

Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group

Frédéric Peyrade, Serge Bologna, Vincent Delwail et al. · The Lancet Haematology · 2016 · 117 citations

Medicine, Hematology, Oncology +9

Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation

Laurent Pascal, Luciana Tucunduva, Annalisa Ruggeri et al. · Blood · 2015 · 76 citations

Medicine, Hematology, Immunology +14

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial

Luc‐Matthieu Fornecker, Julien Lazarovici, Igor Aurer et al. · Journal of Clinical Oncology · 2022 · 75 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series

Nathalie Forgeard, Dikélélé Elessa, Alexander Carpinteiro et al. · Blood · 2023 · 51 citations · Full text

Medicine, Nephrology, Molecular Pathology +4